Trial intelligence / Profile preview

Risedronate in Prevention of Bone Loss in Patients on High Dose Corticosteroids

NCT00372372Phase 4Completed

Sponsor
Tuen Mun Hospital
Start
Jan 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of risedronate in osteoporosis, sponsored by Tuen Mun Hospital. Started Jan 2004; status: completed.

02

Drugs

risedronate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT00372372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00372372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call